Less Survivable Cancers Taskforce


There are some cancers which have seen remarkable progress in survivability but others that are just as deadly as they were 40 years ago. Together they now make up half of all common cancer deaths in the UK.

The Less Survivable Cancer Taskforce represents lung, liver, brain, oesophageal, pancreatic and stomach cancers, all with a five year survival rate of less than 30%. Despite accounting for 51.1% of common cancer deaths the less survivable cancers still suffer from low awareness amongst the public and health practitioners. Delays in diagnosis have a detrimental effect on survival of these rapidly-advancing diseases, which are currently difficult or impossible to treat at later stages.

The aim of the Less Survivable Cancer Taskforce is to see the survivability of the less survivable cancers double by 2029. 

Session title

Improving the treatment of the Less Survivable Cancers

Session synopsis

Currently, in the UK around 70,000 people are diagnosed with one of the less survivable cancers every year. At present, only 14% of people currently live for more than five years after the diagnosis. This session will feature representatives from the Less Survivable Cancer Taskforce to discuss their aim to double survival of the least survivable cancers by 2029.